151 related articles for article (PubMed ID: 2151621)
1. Recent diagnostic modalities for bladder cancer.
Sheinfeld J; Cordon-Cardo C; Bander NH
Immunol Ser; 1990; 53():485-97. PubMed ID: 2151621
[TBL] [Abstract][Full Text] [Related]
2. Early diagnosis and monitoring of superficial transitional cell carcinoma by microsatellite analysis on urine sediment.
Bartoletti R; Dal Canto M; Cai T; Piazzini M; Travaglini F; Gavazzi A; Rizzo M
Oncol Rep; 2005 Mar; 13(3):531-7. PubMed ID: 15706429
[TBL] [Abstract][Full Text] [Related]
3. [Prognostic markers in transitional carcinoma of the bladder].
Blasco E; Gutiérrez-Hoyos A; Garrido C; Arozena F
Arch Esp Urol; 1991; 44(1):47-52. PubMed ID: 2064423
[TBL] [Abstract][Full Text] [Related]
4. Advances in the diagnosis of urothelial neoplasia.
Crissman JD; Zarbo RJ; Johnson T; Babu VR; Sarkar FH; Miles BJ; Cerny JC
Henry Ford Hosp Med J; 1989; 37(1):19-23. PubMed ID: 2670840
[TBL] [Abstract][Full Text] [Related]
5. [Tumor bladder antigen (TBA). A new method for the diagnosis and detection of recurrence of bladder cancer].
Escaf Barmadah S; Martín Benito JL; Fernández Gómez JM; San Martín Blanco A; Pérez Gracia FJ; Rodríguez Martínez JJ
Arch Esp Urol; 1998 Mar; 51(2):129-36. PubMed ID: 9586309
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in bladder cancer diagnostics.
Sanchez-Carbayo M
Clin Biochem; 2004 Jul; 37(7):562-71. PubMed ID: 15234237
[TBL] [Abstract][Full Text] [Related]
7. Current understanding of the biology of advanced bladder cancer.
Al-Sukhun S; Hussain M
Cancer; 2003 Apr; 97(8 Suppl):2064-75. PubMed ID: 12673698
[TBL] [Abstract][Full Text] [Related]
8. Critical appraisal of tumor markers in bladder cancer.
Fradet Y; Cordon-Cardo C
Semin Urol; 1993 Aug; 11(3):145-53. PubMed ID: 8105526
[No Abstract] [Full Text] [Related]
9. Genetic and epigenetic aspects of bladder cancer.
Kim WJ; Quan C
J Cell Biochem; 2005 May; 95(1):24-33. PubMed ID: 15759278
[TBL] [Abstract][Full Text] [Related]
10. [Molecular biology advances and perspectives in urology].
Feria Bernal G; Arroyo Kuribreña JC
Rev Invest Clin; 2003; 55(2):243-7. PubMed ID: 12827935
[No Abstract] [Full Text] [Related]
11. Genetic alterations in bladder cancer and their clinical applications in molecular tumor staging.
Sugano K; Kakizoe T
Nat Clin Pract Urol; 2006 Dec; 3(12):642-52. PubMed ID: 17149381
[TBL] [Abstract][Full Text] [Related]
12. Prognosis in carcinoma of the urinary bladder based upon tissue blood group abh and Thomsen-Friedenreich antigen status and karyotype of the initial tumor.
Summers JL; Coon JS; Ward RM; Falor WH; Miller AW; Weinstein RS
Cancer Res; 1983 Feb; 43(2):934-9. PubMed ID: 6848204
[TBL] [Abstract][Full Text] [Related]
13. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
[TBL] [Abstract][Full Text] [Related]
14. [Molecular biology studies of bladder cancer].
Bringuier PP; Knopf HJ; Schalken JA; Debruyne FM
Urologe A; 1991 May; 30(3):167-71. PubMed ID: 1871935
[TBL] [Abstract][Full Text] [Related]
15. [Tumor markers and prognostic parameters in urinary bladder cancer].
Schneider AW; Huland H
Urologe A; 1990 Mar; 29(2):71-6. PubMed ID: 2184571
[TBL] [Abstract][Full Text] [Related]
16. [Determination of surface ABO(H) isoantigens in transitional cell carcinoma of the bladder. Clinicopathological study. (Part 1)].
Gelabert Mas A; Corominas J; Arango O
Actas Urol Esp; 1988; 12(3):248-53. PubMed ID: 3177059
[No Abstract] [Full Text] [Related]
17. A prospective evaluation of the diagnostic and potential prognostic utility of urinary human telomerase reverse transcriptase mRNA in patients with bladder cancer.
Bowles L; Bialkowska-Hobrzanska H; Bukala B; Nott L; Razvi H
Can J Urol; 2004 Dec; 11(6):2438-44. PubMed ID: 15636669
[TBL] [Abstract][Full Text] [Related]
18. [Serum and tissue quantification of tissue polypeptide antigen (TPA) in transitional cell carcinoma of the bladder].
Moreno Sierra J; Maestro de las Casas ML; Ortega Heredia MD; Blanco Jimenez E; Hermida Gutiérrez J; Resel Estévez L
Arch Esp Urol; 1994 Dec; 47(10):979-84. PubMed ID: 7864679
[TBL] [Abstract][Full Text] [Related]
19. [Low-grade and low-stage transitional carcinoma of the bladder. Review].
Escudero Barrilero A; Gutiérrez Sanz Gadea C; Hernández Fernández C; Romero Maroto J; Tallada Buñuel M; Perales Cabanas L
Actas Urol Esp; 1985; 9(3):203-8. PubMed ID: 3898736
[No Abstract] [Full Text] [Related]
20. [Updating of prognostic factors in bladder carcinoma].
Bellmunt Molins J; Cordón-Cardó C
Med Clin (Barc); 1991 Nov; 97(19):749-54. PubMed ID: 1686925
[No Abstract] [Full Text] [Related]
[Next] [New Search]
